Skip to main content

Advertisement

SpringerLink
Log in

Superantigenic characteristics of mouse mammary tumor viruses play a critical role in susceptibility to infection in mice

  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Mouse mammary tumor viruses (MMTV) are retroviruses that induce mammary carcinomas. An interesting feature of these viruses is the superantigen (SAg) encoded in an open reading frame within the 3′ long terminal repeat. The mechanism by which ingestion of milk-borne virus results in infection of the host mammary tissue remains incompletely understood. However, a working model has been proposed in which the interaction between viral SAg, T-cell receptor and MHC class II I-E facilitates viral replication and hence infectivity. In this review we summarize current studies demonstrating the role of SAg stimulation in susceptibility to MMTV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Festenstein H: Immunogenetic and biological aspects of in vitro lymphocyte allotransformation (MLR) in the mouse. Transplant Rev 1973; 15:62–68.

    PubMed  CAS  Google Scholar 

  2. Frankel WN, Rudy C, Coffin JM, Huber BT: Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice. Nature 1991; 349:526–528.

    Article  PubMed  CAS  Google Scholar 

  3. Marrack P, Kushnir E, Kappler J: A maternally inherited superantigen encoded by mammary tumour viruses. Nature 1991;349:524–526.

    Article  PubMed  CAS  Google Scholar 

  4. Fleischer B, Hartwig U: T lymphocyte stimulation by microbial superantigens. Chem Immunol 1992;55: 56–64.

    Google Scholar 

  5. Marrack P, Kappler J: The staphylococcal enterotoxins and their relatives. Science 1990;248:705–711.

    Article  PubMed  CAS  Google Scholar 

  6. Tomai MA, Aelion JA, Dockter ME, Majumdar G, Spinella DG, Kolb M: T cell receptor V gene usage by human T cells stimulated with the superantigen streptococcal M protein. J Exp Med 1991;174:285–288.

    Article  PubMed  CAS  Google Scholar 

  7. Hügin AW, Vacchio MS, Morse HC III: A virus-encoded superantigen in a retrovirus-induced immunodeficiency syndrome. Science 1991;252: 424–429.

    Article  PubMed  Google Scholar 

  8. Kanagawa O, Nussrallah BA, Wiebenga ME, Murphy KM, Morse HC, Carbone FR: Murine AIDS superantigen reactivity of the T cells bearing Vβ5 T cell antigen receptor. J Immunol 1992;149:9–16.

    PubMed  CAS  Google Scholar 

  9. Acha-Orbea H: Retroviral superantigens. Immunology 1992;55:65–86.

    CAS  Google Scholar 

  10. Cole BC, Atkin CL: TheMycoplasma arthritidis T-cell mitogen, MAM, a model superantigen. Immunol Today 1991;12:271–275.

    Article  PubMed  CAS  Google Scholar 

  11. Kronenberg M, Siu G, Hood L, Shastri N: The molecular genetics of the T cell antigen receptor and T cell antigen recognition. Annu Rev Immunol 1986;4:529–592.

    Article  PubMed  CAS  Google Scholar 

  12. Fink P, Matis L, McElligot D, Bookman M, Hedrick M: Correlations between T cell specificity and structure of the T cell receptor. Nature 1986;321:219–226.

    Article  PubMed  CAS  Google Scholar 

  13. Davis MM, Bjorkman PJ: T-cell antigen receptor genes and T-cell recognition. Nature 1988;334:395–401.

    Article  PubMed  CAS  Google Scholar 

  14. Abe R, Vacchio MS, Fox B, Hodes RJ: Preferential expression of the T-cell receptor Vβ3 gene by Mlsc reactive T cells. Nature 1988;335:827–830.

    Article  PubMed  CAS  Google Scholar 

  15. Pullen AM, Wade T, Marrack P, Kappler JW: Identification of the region of T cell receptor β chain that interacts with self superantigen Mls-1a. Cell 1988;61:1365–1374.

    Article  Google Scholar 

  16. Choi Y, Herman A, DiGiusto D, Wade T, Marrack P, Kappler J: Residues of the variable region of the T-cell-receptor β-chain that interact withS. aureus toxin superantigen. Nature 1990;346:471–473.

    Article  PubMed  CAS  Google Scholar 

  17. Bellio M, Lone YC, de la Calle-Martin O, Malissen B, Abastado JP, Kourilsky P: The Vβ complementarity determining region 1 of a major histocompatibility complex (MHC) class I-restricted T cell receptor is involved in the recognition of peptide/MHC I and superantigen/MHC II complex. J Exp Med 1994;179: 1087–1097.

    Article  PubMed  CAS  Google Scholar 

  18. White J, Pullen A, Choi K, Marrack P, Kappler JW: Antigen recognition properties of mutant Vβ3+ T cell receptors are consistent with an immunoglobulin-like structure for the receptor. J Exp Med 1993;177:119–125.

    Article  PubMed  CAS  Google Scholar 

  19. Pontzer CH, Irwin, MJ, Gascoigne NRJ, Johnson HM: T-cell antigen receptor binding sites for the microbial superantigen staphylococcal enterotoxin A. Proc Natl Acad Sci USA 1992;89:7727–7731.

    Article  PubMed  CAS  Google Scholar 

  20. Vacchio MS, Kanagawa O, Tomonari K, Hodes RJ: Influence of T cell receptor Vα expression on Mlsa superantigen-specific T cell responses. J Exp Med 1992;175:1405–1408.

    Article  PubMed  CAS  Google Scholar 

  21. Smith HP, Le P, Woodland DL, Blackman, MA: T cell receptor α-chain influences reactivity to Mls-1 in Vβ8.1 transgenic mice. J Immunol 1992;149:887–896.

    PubMed  CAS  Google Scholar 

  22. Woodland DL, Smith HP, Surman S, Le P, Wen R, Blackman MA: Major histocompatibility complex-specific recognition of Mls-1 is mediated by multiple elements of the T cell receptor. J Exp Med 1993;177:433–442.

    Article  PubMed  CAS  Google Scholar 

  23. Rock EP, Sibbald PR, Davis MM, Chien YH: CDR3 length in antigen-specific immune responses J Exp Med 1994;179:323–328.

    Article  PubMed  CAS  Google Scholar 

  24. Sprent J: T lymphocytes and the thymus; in Paul WE (ed): Fundamental Immunology, ed 3. New York, Raven Press, 1993, pp 80–81.

    Google Scholar 

  25. Torres BA, Griggs ND, Johnson HM: Bacterial and retroviral superantigens share a common binding region on class II MHC antigens. Nature 1993;364:152–154.

    Article  PubMed  CAS  Google Scholar 

  26. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Chi YI, Stauffacher C, Strominger JL, Wiley DC: Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 1994;368:711–718.

    Article  PubMed  CAS  Google Scholar 

  27. Patten PA, Rock EP, Sonoda T, de Fazekas St, Groth B, Jorgensen JL, Davis MM: Transfer of putative complementarity-determining loops of T cell receptor V domains confers toxin reactivity but not peptide/MHC specificity. J Immunol 1993; 150:2281–2294.

    PubMed  CAS  Google Scholar 

  28. Herman A, Croteau G, Sekaly RP, Kappler J, Marrack P: HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells. J Exp Med 1990;172:709–717.

    Article  PubMed  CAS  Google Scholar 

  29. Fraser JD: High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR Nature 1989;339:221–224.

    Article  PubMed  CAS  Google Scholar 

  30. Winslow GM, Scherer MT, Kappler JW, Marrack P: Detection and biochemical characterization of the mouse mammary tumour virus 7 superantigen (Mls-1a). Cell 1992;71:719–730.

    Article  PubMed  CAS  Google Scholar 

  31. Mollick JA, McMasters RL, Grossman D, Rich RR: Localization of a site on bacterial superantigens that determines T cell receptor β chain specificity. J Exp Med 1993;177: 283–293.

    Article  PubMed  CAS  Google Scholar 

  32. Choi Y, Marrack P, Kappler JW: Structural analysis of a mouse mammary tumor virus superantigen. J Exp Med 1992;175:847–852.

    Article  PubMed  CAS  Google Scholar 

  33. Bergdoll MS: Staphylococcal intoxication; in Riemann H, Bryan Fl (eds): Food-Borne Infections and Intoxications, ed 2, New York, Academic Press, 1979, pp 443–494.

    Google Scholar 

  34. Todd JK, Fishaut M, Kapral F, Welch T: Toxic shock syndrome associated with phage-group 1 staphylococci. Lancet 1978;ii:1116–1118.

    Article  Google Scholar 

  35. Stevens DL, Tanner MH, Winship J: Group A streptococcal infections associated with toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989;321:1–7.

    PubMed  CAS  Google Scholar 

  36. Imberti L, Sottini A, Bettinardi A, Puoti M, Primi D: Selective depletion in HIV infection of T cells that bear specific T cell receptor Vβ sequences. Science 1991;254:860–862.

    Article  PubMed  CAS  Google Scholar 

  37. Laurence J, Hodtsev AS, Posnett DN: Superantigen implicated in dependence of HIV-1 replication in T cells on TCR Vβ expression. Nature 1992;358:255–259.

    Article  PubMed  CAS  Google Scholar 

  38. Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D, Lotteau V, Scott-Algara D: Evidence for a viral superantigen in humans. Nature 1992;358:507–510.

    Article  PubMed  CAS  Google Scholar 

  39. Cole BC, Ward JR, Jones RS, Cahill JF: Chronic proliferative arthritis of mice induced byMycoplasma arthritidis. I. Induction of disease and histopathological characteristics. Infect Immun 1971;4:344–355.

    PubMed  CAS  Google Scholar 

  40. Cole BC, Balderas RA, Ahmed EA, Kono D, Theofilopoulos AN: Genomic composition and allelic polymorphisms influence Vβ usage by theMycoplasma arthritidis superantigen. J Immunol 1993;150:3291–3299.

    PubMed  CAS  Google Scholar 

  41. Posnett DN: Do superantigens play a critical role in autoimmunity? Semin Immunol 1993;5:65–72.

    Article  PubMed  CAS  Google Scholar 

  42. Abe J, Kotzin BL, Jujo K, Melish ME: Selective expansion of T cells expressing TCR variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc Natl Acad Sci USA 1992;8: 4066–4070.

    Article  Google Scholar 

  43. Kotzin BL, Leung DY, Kappler J, Marrack P: Superantigens and their potential role in human disease. Adv Immunol 1993;54:99–166.

    Article  PubMed  CAS  Google Scholar 

  44. Sagle BL, Butel JS: Exogenous and endogenous mouse mammary tumor viruses: Replication and transformation; in Medina D, Kidwell W, Heppner G, Anderson E (eds): Cellular and Molecular Biology of Mammary Cancer. New York, Plenum Press, 1987, pp 275–306.

    Google Scholar 

  45. Choi Y, Kappler JW, Marrack P: A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumor virus. Nature 1991;350:203–207.

    Article  PubMed  CAS  Google Scholar 

  46. Acha-Orbea H, Shakhov AN, Scarpellino L, Kolb E, Muller V, Vessaz-Shaw A, Fuchs R, Blochlinger K, Rollini P, Billotte J, Sarafilder M, McDonald HR, Diggelman H: Clonal deletion of Vβ14-bearing T cells in mice transgenic for mammary tumor virus. Nature 1991;350:207–211.

    Article  PubMed  CAS  Google Scholar 

  47. Golovkina TV, Chervonsky A, Dudley JP, Ross SR: Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 1992;69:637–645.

    Article  PubMed  CAS  Google Scholar 

  48. Acha-Orbea H, Held W, Waanders GA, Shakhov N, Scarpellino L, Lees RK, MacDonald HR: Exogenous and endogenous mouse mammary tumor virus superantigens. Immunol Rev 1993;131:5–25.

    Article  PubMed  CAS  Google Scholar 

  49. Lefebvre P, Berard DS, Cordingely MG, Hager GL: Two regions of the mouse mammary tumor virus long terminal repeat regulate the activity of its promoter in mammary cell lines. Mol Cell Biol 1991;11:2529–2537.

    PubMed  CAS  Google Scholar 

  50. Kain SR, Platt EJ, Brown KS, Black N, Firestone GL: Disruptions in intracellular membrane trafficking and structure preclude the glucocorticoid-dependant maturation of mouse mammary tumor virus proteins in rat hepatoma cells. J Biol Chem 1992;267:8182–8132.

    Google Scholar 

  51. Pucillo CEM, Cepeda R, Hodes RJ: Expression of a MHC class II transgene determines both superantigenicity and susceptibility to mammary tumor virus infection. J Exp Med 1993;178:1441–1445.

    Article  PubMed  CAS  Google Scholar 

  52. Marrack P, Lo D, Brinster R, Palmiter R, Burkly L, Flavell KH, Kappler J: The effect of thymus environment on T cell development and tolerance. Cell 1988;53:627–634.

    Article  PubMed  CAS  Google Scholar 

  53. Waanders GA, Shakhov AN, Held W, Karapetian O, Acha-Orbea H, MacDonald HR: Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus. J Exp Med 1993;177:1359–1366.

    Article  PubMed  CAS  Google Scholar 

  54. Hodes RJ, Novick MB, Palmer LD, Knepper JE: Association of a Vβ2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus. J Immunol 1993;150: 1422–1428.

    PubMed  CAS  Google Scholar 

  55. Held W, Acha-Orbea H, MacDonald HR, Waanders GA: Superantigens and retroviral infection: Insight from mouse mammary tumor virus. Immunol Today 1994;15:184–190.

    Article  PubMed  CAS  Google Scholar 

  56. Bette M, Schäfer MKH, van Rooijen N, Weihe E, Fleischer B: Distribution and kinetics of superantigen-induced cytokine gene expression in mouse spleen. J Exp Med 1993;178:1531–1540.

    Article  PubMed  CAS  Google Scholar 

  57. Cardell S, Höidén I, Möller G: Manipulation of the superantigen-induced lymphokine response. Selective induction of interleukin-10 or interferon-γ synthesis in small resting CD4+ T cells. Eur J Immunol 1993;23:523–529.

    Article  PubMed  CAS  Google Scholar 

  58. Held W, Shakhov AN, Izui S, Waanders GA, Scarpellino L, MacDonald HR, Acha-Orbea H: Superantigen-reactive CD4+ cells are required to stimulate B cells after infection with mouse mammary tumor virus. J Exp Med 1993;177:359–366.

    Article  PubMed  CAS  Google Scholar 

  59. MacDonald HR, Baschieri S, Lees RK: Clonal expansion precedes anergy and death of Vβ8+ peripheral T cells responding to staphylococcal enterotoxin B in vivo. Eur J Immunol 1991;21:1963–1966.

    Article  PubMed  CAS  Google Scholar 

  60. Ignatowicz L, Kappler J, Marrack P: The effects of chronic infection with a superantigen-producing virus. J Exp Med 1992;175:917–923.

    Article  PubMed  CAS  Google Scholar 

  61. Beutner U, Kraus E, Kitamura D, rajewsky K, Huber BT: B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J Exp Med 1994;179: 1457–1466.

    Article  PubMed  CAS  Google Scholar 

  62. Gollob KJ, Palmer E: Aberrant induction of T cell tolerance in B cell suppressed mice. J Immunol 1993; 150:3705–3712.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Experimental Immunology Branch, National Cancer Institute and National Institute on Aging, National Institutes of Health, Building 10, Room 4B17, 10 Center Drive MSC 1360, 20892-1360, Bethesda, Md., USA

    Carlo E. M. Pucillo, Larry D. Palmer & Richard J. Hodes

Authors
  1. Carlo E. M. Pucillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Larry D. Palmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard J. Hodes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pucillo, C.E.M., Palmer, L.D. & Hodes, R.J. Superantigenic characteristics of mouse mammary tumor viruses play a critical role in susceptibility to infection in mice. Immunol Res 14, 58–68 (1995). https://doi.org/10.1007/BF02918497

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02918497

Key Words

Search

Navigation